Open access · OA
via OpenAlex
Prevention of Age-Related Macular Degeneration–Like Retinopathy by Rapamycin in Rats
Н. Г. Колосова, Natalia A. Muraleva, А. А. Жданкина, Natalia A. Stefanova, А. Ж. Фурсова, Mikhail V. Blagosklonny
American Journal Of Pathology · 2012 · ▲ 81 citations
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.ajpath.2012.04.018
- Canonical
- link ↗
- Fetched
- 2026-06-13 MST
Cite this
APA
Колосова, �.�., Muraleva, N.A., Жданкина, �.�., Stefanova, N.A., Фурсова, �.�., & Blagosklonny, M.V. (2012). Prevention of Age-Related Macular Degeneration–Like Retinopathy by Rapamycin in Rats. <em>American Journal Of Pathology</em>. https://doi.org/10.1016/j.ajpath.2012.04.018
Vancouver
Колосова ��, Muraleva NA, Жданкина ��, Stefanova NA, Фурсова ��, Blagosklonny MV. Prevention of Age-Related Macular Degeneration–Like Retinopathy by Rapamycin in Rats. American Journal Of Pathology. 2012. doi:10.1016/j.ajpath.2012.04.018.
BibTeX
@article{2012Preven,
title = {Prevention of Age-Related Macular Degeneration–Like Retinopathy by Rapamycin in Rats},
author = {Н. Г. Колосова and Natalia A. Muraleva and А. А. Жданкина and Natalia A. Stefanova and А. Ж. Фурсова and Mikhail V. Blagosklonny},
journal = {American Journal Of Pathology},
year = {2012},
doi = {10.1016/j.ajpath.2012.04.018},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Ophthalmic surgery, lasers & imaging retina 2026
Citation only
Photobiomodulation for Dry Age-related Macular Degeneration.
Eye 2014
Open access · OA
The role of epigenetics in age-related macular degeneration
Experimental Eye Research 2025
Preprint · OA
Features that distinguish age-related macular degeneration from aging
Biomedicines 2026
Open access · OA
Metagenomic Profiling of the Gut Microbiome in Age-Related Macular Degeneration—A Pilot Study
Journal of clinical and translational science
Open access · OA
415 Designing nanoparticle therapies for age-related macular degeneration
JAMA ophthalmology 2026
Citation only